Beta-Alanine at 40 mg vs. the Research Dose: What It Does and Doesn't Do
MemoHoney's 40 mg of Beta-Alanine is roughly 1–2% of the 2,000–6,000 mg daily dose used in performance research. At this amount it will not meaningfully raise muscle carnosine or cause the tingling side effect. Treat it as a minor supporting ingredient, not a reason to buy.
- 40 mg per capsule
- Research: 2,000–6,000 mg/day
- No tingling at this dose
- Minor supporting role
What Beta-Alanine is studied for
Beta-Alanine is a non-essential amino acid whose main job in supplementation is to raise muscle carnosine. Carnosine buffers hydrogen ions that accumulate during intense effort, delaying the burning sensation and fatigue in efforts lasting one to four minutes. That is why it lives in pre-workouts and endurance formulas, and why the International Society of Sports Nutrition's position stand treats it as an ergogenic aid at 4–6 g per day.
A second, smaller body of work looks at carnosine's antioxidant and anti-glycation activity in tissue, including brain tissue in animal models. This is the thread cognitive-support formulas pull on when they include Beta-Alanine. The mechanism is real; the human evidence for a cognitive benefit is thin, and all of it uses gram-level dosing.
How dosing works for this ingredient
Beta-Alanine is a loading ingredient. Muscle carnosine rises slowly with daily intake and plateaus after four to ten weeks; the standard protocol is 3.2–6.4 g per day split into small doses. A single 40 mg serving is not a fraction of a working dose so much as a rounding error against it — you would need to take fifty MemoHoney capsules to reach the low end of the research range.
The one thing 40 mg reliably avoids is paraesthesia, the harmless pins-and-needles flush that begins for most people around 800 mg in a single dose. If you have ever tried a pre-workout and disliked the tingling, MemoHoney will not reproduce it.
Why a formula would include such a small amount
There are three plausible reasons. First, label presence: the ingredient name carries recognition from the sports market. Second, capsule space: a once-daily capsule can only hold roughly 700–800 mg of total actives, and most of MemoHoney's budget goes to the amino acids on the nitric oxide pathway. Third, cost. None of these are sinister, but none of them make 40 mg an active dose either.
The right way to read it is as a formulation footnote. The disclosed label deserves credit for making that visible; a proprietary blend would have let the ingredient imply far more than it delivers.
What you should expect from 40 mg
Nothing you could attribute specifically to Beta-Alanine. No endurance change, no tingling, no measurable carnosine increase. If MemoHoney helps you, it will be through the nitric oxide precursors and the niacin, and the Beta-Alanine line on the label should not move your purchase decision in either direction.
What this means for MemoHoney
MemoHoney's honest label lets us say plainly that Beta-Alanine is not a working ingredient at 40 mg. The formula's case rests on the ~600 mg of arginine and citrulline and the 7.5 mg NE of niacin — judge it on those.
| Ingredient | Per capsule | Research / RDA range |
|---|---|---|
| Niacin (Vitamin B3) | 7.5 mg NE | 14–16 mg NE (RDA) |
| Calcium | 18 mg | 1,000–1,200 mg (RDA) |
| L-Arginine (base) | 200 mg | 3,000–6,000 mg |
| L-Arginine AKG 2:1 | 200 mg | 3,000–6,000 mg |
| L-Citrulline HCl | 100 mg | 3,000–8,000 mg |
| L-Citrulline Malate | 100 mg | 3,000–8,000 mg |
| Beta-Alanine | 40 mg | 2,000–6,000 mg |
Every MemoHoney amount is printed on the label — no proprietary blend. Full analysis on the ingredients page; mechanism on how it works.
Key takeaways
- Research doses of Beta-Alanine are 50–150× MemoHoney's 40 mg.
- No tingling side effect at this amount.
- Consider it a footnote; evaluate the formula on its nitric oxide precursors and niacin.
FAQ
No. Paraesthesia typically starts around 800 mg in a single dose. 40 mg is twenty times below that.
Only if you have an endurance-training goal. For cognitive support there is no established human dose to target.
Carnosine and its precursors are found in brain tissue, and animal work shows antioxidant activity there, but human cognitive trials are lacking.